Taro Pharmaceutical Industries Ltd. Board of Directors to Evaluate Unsolicited Tender Offer From Sun Pharmaceutical Industries Ltd

HAWTHORNE, N.Y., June 30, 2008 (PRIME NEWSWIRE) -- Taro Pharmaceutical Industries Ltd. (“Taro” or the “Company”) (Pink Sheets:TAROF) said today that it would have no formal comment on the unsolicited tender offer commenced today by a subsidiary of Sun Pharmaceutical Industries Ltd. (“Sun”), for all shares of Taro common stock at a price of $7.75 per share until Taro’s Board of Directors has an opportunity to review and evaluate the full details of the offer.

MORE ON THIS TOPIC